$38.50
0.551.45%
Dern. MÀJ: Oct 29, 7:00 AM
Harmony Biosciences Hldgs (HRMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
fiscal year (2026) a publié ses dernières prévisions le $1B - $1.04B pour Harmony Biosciences Hldgs {{epsDirection}}. La société a prévu un chiffre d'affaires compris entre {{epsPriorRange}} et {{revenueDirection}} pour la période.
Par rapport aux prévisions précédentes, {{newestDate}} {{directionSummary}} ses prévisions de chiffre d'affaires ont été revues à la baisse, passant d'une fourchette précédente de undefined à undefined.
undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.05 | $0.90 | $0.98 | $0.88 |
| Actual | $1.28 | $0.55 | $0.57 | $1.08 |
| Surprise | +21.9% | -38.9% | -41.8% | +22.7% |
| Revenue | ||||
| Estimate | $242.1M | $221.2M | $241.5M | $225.2M |
| Actual | $261.3M | $215.4M | $243.8M | $239.5M |
| Surprise | +7.91% | -2.61% | +0.95% | +6.33% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.38 | $1.42 | $0.83 | $0.98 |
| Revenue | ||||
| Consensus | $273.2M | $281.4M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.28 | $1.05 | 21.9 % |
| Q1 | May 7, 2026 | $0.55 | $0.90 | -38.9 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.98 | -41.8 % |
| Q3 | Nov 4, 2025 | $1.08 | $0.88 | 22.7 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $261.30M | $242.15M | 7.91 % |
| Q1 | May 7, 2026 | $215.40M | $221.17M | -2.61 % |
| Q4 | Feb 24, 2026 | $243.78M | $241.47M | 0.95 % |
| Q3 | Nov 4, 2025 | $239.46M | $225.19M | 6.33 % |